N85.0 Endometrial hyperplasia

Name of the Condition

• Endometrial hyperplasia

Summary

Endometrial hyperplasia is a condition characterized by the abnormal thickening of the endometrium, the lining of the uterus. This occurs due to an overgrowth of cells, often driven by hormonal imbalances. It is a precancerous condition that requires medical evaluation to assess the risk of progression to endometrial cancer.

Causes

The primary cause of endometrial hyperplasia is an excess of estrogen relative to progesterone. This imbalance can lead to uncontrolled cell growth in the endometrium. Conditions that disrupt the normal estrogen-progesterone ratio, such as anovulation or estrogen-producing tumors, may contribute to its development.

Risk Factors

• Obesity, which increases estrogen production
• Polycystic ovary syndrome (PCOS)
• Estrogen-only hormone therapy without progesterone
• Late menopause
• Nulliparity (never having given birth)
• Family history of endometrial or colorectal cancer
• Diabetes or insulin resistance

Symptoms

• Abnormal uterine bleeding, such as heavy or prolonged menstrual periods
• Bleeding between periods (intermenstrual bleeding)
• Postmenopausal bleeding
• Pelvic pain or pressure in some cases

Diagnosis

Diagnosis typically involves a combination of clinical evaluation and diagnostic tests. A transvaginal ultrasound may be used to assess endometrial thickness. An endometrial biopsy, often performed via hysteroscopy, is the definitive method to confirm the diagnosis and classify the hyperplasia as simple, complex, or atypical.

Treatment Options

Treatment depends on the type and severity of hyperplasia. Options may include:

• Progesterone therapy (oral, intrauterine, or injectable) to counteract estrogen effects
• Hormonal intrauterine devices (IUDs) for localized treatment
• Surgical intervention, such as dilation and curettage (D&C) or hysterectomy, for atypical or severe cases
• Lifestyle modifications, such as weight management, to reduce estrogen exposure

Prognosis and Follow-Up

The prognosis varies based on the type of hyperplasia. Simple hyperplasia without atypia has a low risk of progressing to cancer, while atypical hyperplasia carries a higher risk. Regular follow-up, including repeat biopsies or imaging, is essential to monitor for changes. Early detection and treatment significantly improve outcomes.

Complications

• Progression to endometrial cancer, particularly with atypical hyperplasia
• Persistent abnormal bleeding affecting quality of life
• Anemia due to heavy menstrual bleeding
• Infertility in some cases

Lifestyle & Prevention

• Maintain a healthy weight to reduce estrogen production
• Use combined hormone therapy (estrogen plus progesterone) if hormone replacement is needed
• Manage conditions like PCOS or diabetes effectively
• Avoid unopposed estrogen use without progesterone

When to Seek Professional Help

Seek medical attention if you experience:

• Unusual vaginal bleeding, especially postmenopausal bleeding
• Heavy or prolonged menstrual periods
• Pelvic pain or discomfort
• Symptoms that persist or worsen despite initial treatment

Tips for Medical Coders

When coding for endometrial hyperplasia (ICD-10-CM code N85.0), ensure documentation supports the diagnosis, including clinical findings, biopsy results, and any associated risk factors. Note the absence or presence of atypia, as this may impact coding specificity in related scenarios. Verify that the code aligns with the clinical documentation and any applicable guidelines for precancerous conditions.